#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Frostbite Haemophilia A with anti factor VIII Glomerulonephritis chronic Cholangiosarcoma Postprandial hypoglycaemia Myotonia Pustular psoriasis Non-Hodgkin's lymphoma unspecified histology indolent Idiopathic intracranial hypertension Primary myelofibrosis Neurofibromatosis Transferrin decreased Non-Hodgkin's lymphoma refractory Myeloid leukaemia Chronic myelomonocytic leukaemia More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Trials in Disease Shprintzen-Goldberg syndrome Soft tissue sarcoma – Life with Disease Pleomorphic leiomyosarcoma – Life with Disease Retinitis pigmentosa – Treatment Adrenocortical carcinoma – Basic Information Marginal zone lymphoma – Treatment Ornithine transcarbamoylase deficiency – Basic Information Factor VIII deficiency – Basic Information Fabry’s disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Secale Cereale MALIC ACID Bgb-A445 Bexotegrast Orismilast VX-993 Asparaginase Cldn6 Rna-Lpx RO7837195 Transcon Il-2Β/Γ Bi 706321 Navtemadlin Talquetamab Ibuprofen Lysine AMMONIUM (15N) CHLORIDE Eprosartan Mesilate Elenestinib Phosphate Bms-986435 Crovalimab Glipizide More therapies…

    Learn about Your Condition

    Hepatic encephalopathy Tooth loss Affective disorder Insomnia Arginase deficiency Systemic candida Venous thrombosis Gastric cancer Oesophageal adenocarcinoma Clinically isolated syndrome Immune-mediated myositis Pancreatic fistula Reperfusion injury Retroperitoneal cancer Retinoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Tambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Venetoclax
    • Azacitidine
    Italy Spain

  • MV140 for Women with Recurrent Uncomplicated Urinary Tract Infections

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Nitrofurantoin
    • Pivmecillinam Hydrochloride
    • Ascorbic Acid
    Portugal

  • Temocillin Compared with Ceftriaxone for Gonorrhea Infection in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Temocillin Sodium
    • Ceftriaxone Sodium
    France

  • Anakinra for Sepsis and Hyperinflammation in Pediatric Cancer Patients in the Intensive Care Unit

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Early Saline Pleural Irrigation for Patients with Complicated Pleural Infections

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infectious pleural effusion
    Investigated Drugs:
    • Urokinase
    • Piperacillin
    • Tazobactam
    France

  • 68Ga-DOTATATE PET/CT Prognostic Assessment in Patients with Well-Differentiated Grade 2 Gastroenteropancreatic Neuroendocrine Tumors Treated with 177Lu-oxodotreotide and Edotreotide

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated Drugs:
    • Edotreotide
    France
Previous Page
1 … 708 709 710 711 712 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!